Belluscura Receives Purchase Orders for Portable Oxygen Concentrator

Belluscura saw a surge in its shares today following the announcement that the company has received purchase orders for over 6,500 units of its portable oxygen concentrator. This influx of orders represents an estimated $15 million in potential revenue.

As of 0702 GMT, shares were up 32% at 49 pence, showing a promising trajectory for the London-listed developer of medical devices.

These recent orders come after Belluscura successfully secured distribution agreements with various medical device distributors and home healthcare providers. Additionally, it has received numerous requests from leading oxygen homecare providers in the U.S. to distribute its DISCOV-R product.

Chief Executive Bob Rauker commented on the significant number of orders received, stating that it reflects the strong demand for their product. He added, "We anticipate adding several more of these providers to our distribution network as we continue to meet the high demand while maintaining production expectations over the next year."

Belluscura's portable oxygen concentrator has proven to be a game-changer in the industry, and with the growing demand, the company is poised for further expansion.

Image Source